Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Experimental Oncology
  • Published:

Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma

British Journal of Cancer volume 73, pages 794–797 (1996)Cite this article

Abstract

In a multicentre study, 83 patients with advanced and previously uniformly treated multiple myeloma (MM) were randomised between cyclophosphamide (600 mg m-2) and epirubicin (70 mg m-2), administered every 3 weeks for three courses and both associated with prednisone and interferon-alpha2b. Both regimens were administered on an outpatient basis and had low haematological toxicity. Clinical results were similar. Overall response rate (43%) and median response and survival (5.9 and 14.1 months respectively) compare well with those obtained with more aggressive chemotherapy schedules.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Medicina Interna ed Oncologia Medica, Universita and Istituto di Ricovero e Cura a Carattere Scientifico Policlinico S. Matteo, Pavia, Italy

    S Brugnatelli

Authors
  1. S Brugnatelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Riccardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G Ucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O Mora
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Barbarano
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Piva
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L Piccinini
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. C Bergonzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A De Paoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. M Di Stasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. E Rinaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. G Trotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. M Petrini
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. E Ascari
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

(for the Cooperative Group of Study and Treatment of Multiple Myeloma)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brugnatelli, S., Riccardi, A., Ucci, G. et al. Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. Br J Cancer 73, 794–797 (1996). https://doi.org/10.1038/bjc.1996.138

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1996.138

Search

Advanced search

Quick links